New strategy to attack aggressive brain cancer shows promise
WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients.
Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least temporarily, researchers reported Wednesday.
So-called CAR-T therapy already is used to fight blood-related cancers like leukemia but researchers have struggled to make it work for solid tumors. Now separate teams at Massachusetts General Hospital and the University of Pennsylvania are developing next-generation CAR-T versions designed to get past some of glioblastoma’s defenses.
“It’s very early days,” cautioned Penn’s Dr. Stephen Bagley, who led one of the studies. But “we’re optimistic that we’ve got something to build on here, a real foundation.”
Related articles
Who is Jacob Zuma, the former South African president disqualified from next week's election?
JOHANNESBURG (AP) — Former South African President Jacob Zuma was barred Monday from running for Par2024-05-21Experts Highlight Tibet's Achievements in Promoting Culture, People's Well
Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-21Xinhua Headlines: From Serfdom to Freedom — Tibet's Progress on Democracy, Human Rights
Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-21Art Class Enables Children with Autism to Socialize
Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-21Kosovo prepares a new draft law on renting prison cells to Denmark after the first proposal failed
PRISTINA, Kosovo (AP) — Kosovo’s Cabinet renewed efforts with a new draft law on renting a prison in2024-05-21China's Migrant Workers Enjoy Higher Income in 2021
Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-21
atest comment